NCT05664711View on ClinicalTrials.gov

Effect of Stellate Ganglion Block on ME/CFS

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

December 21, 2023

Study Completion Date

January 15, 2024

Conditions
Encephalomyelitis, MyalgicChronic Fatigue SyndromeChronic Fatigue DisorderChronic Fatigue and Immune Dysfunction SyndromeMyalgic EncephalomyelitisPostviral Fatigue SyndromeSystemic Exertion Intolerance DiseaseInfectious Mononucleosis-Like Syndrome, ChronicChronic Fatigue-Fibromyalgia Syndrome
Interventions
DRUG

Bupivacaine Injection

"Reciprocal unilateral stellate ganglion blocks, separated by at least 16 hours, will be given once per week for three weeks (for a total of 6 blocks).~This study is not intended to be reported to FDA as a well-controlled study in support of a new indication for bupivacaine or to support any other significant change in the labeling for the drug."

Trial Locations (1)

99508

Neuroversion, Anchorage

All Listed Sponsors
lead

Neuroversion, Inc.

OTHER